Immunomedics Inc (NASDAQ:IMMU)

During the Trading Day
3.33 +0.15 / +4.72%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.37 +0.04 / +1.20%
Volume: 2.8K
Health Technology

Company Description

Immunomedics, Inc. is a biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. Immunomedics was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Contact Information

Immunomedics, Inc.
300 The American Road
Morris Plains New Jersey 07950
P:(973) 605-8200
Investor Relations:



Individual stakeholders7.13%
Mutual fund holders25.06%
Other institutional16.86%

Top Executives

David M. GoldenbergChairman, Chief Scientific & Medical Officer
Cynthia L. SullivanPresident, Chief Executive Officer & Director
Peter P. PfreundschuhChief Financial Officer & Vice President-Finance
William A. WegenerSenior Vice President-Clinical Research
Hans J. HansenVice President-Emeritus

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.